| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.005 |